ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE

Main Article Content

Eleonora Boscaro
a:1:{s:5:"en_US";s:42:"A.O.U. City of Health and Science of Turin";}

Keywords

acute leukemia, acute promyelocytic leukemia, Differentiation Syndrome, retinal detachment

Downloads

Download data is not yet available.


Abstract 23
PDF Downloads 11
HTML Downloads 3

References

1. Gasparovic L, Weiler S, Higi L, Burden AM. Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature. J Clin Med. 2020;9(10). doi:10.3390/jcm9103342
2. Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157-162. doi:10.1111/bjh.16151
3. Rego EM, De Santis GC. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment. Mediterr J Hematol Infect Dis. 2011;3(1):e2011048. doi:10.4084/MJHID.2011.048
4. Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. N Engl J Med. 2013;369(2):111-121. doi:10.1056/NEJMoa1300874
5. Sanz MA, Lo Coco F, Martín G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96(4):1247-1253.
6. Sanz MA, Montesinos P. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood. 2014;123(18):2777-2782. doi:10.1182/blood-2013-10-512640
7. Luesink M, Pennings JLA, Wissink WM, et al. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009;114(27):5512-5521. doi:10.1182/blood-2009-02-204834
8. Newman AR, Leung B, Richards A, Campbell TG, Wellwood J, Imrie FR. Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide. Am J Ophthalmol Case Rep. 2018;9:106-111. doi:10.1016/j.ajoc.2018.01.026
9. Levasseur SD, Tantiworawik A, Lambert Maberley DA. All-trans retinoic Acid differentiation syndrome chorioretinopathy: a case of multifocal serous neurosensory detachments in a patient with acute promyelocytic leukemia treated with all-trans retinoic Acid. Retin Cases Brief Rep. 2013;7(1):46-49. doi:10.1097/ICB.0b013e3182618d6c
10. Hua HU, Rayess N, Moshfeghi AA. Acute Promyelocytic Leukemia With Sudden Vision Loss. JAMA Ophthalmol. 2020;138(2):206-207. doi:10.1001/jamaophthalmol.2019.4838
11. Tam EK, Ness S, Peeler CE. Exudative hemorrhagic retinopathy related to all-trans retinoic acid differentiation syndrome in a patient with acute promyelocytic leukemia. Int J Ophthalmol. 2021;14(2):323-325. doi:10.18240/ijo.2021.02.22

Article Sidebar

PDF HTML
Published
Jun 29, 2024
DOI https://doi.org/10.4084/MJHID.2024.063

Article Details

How to Cite

Boscaro, E. (2024) “ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE”, Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024063. doi: 10.4084/MJHID.2024.063.
Issue
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.